Shufro Rose & Co’s NEOPHOTONICS CORP NPTN Stock Holding History

Shufro Rose & Co’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-112,300	Closed	-$758K	–	269
2015 Q1	$758K	Sell	112,300 -45,000	-29%	-$181K	0.08%	141
2014 Q4	$531K	Sell	157,300 -10,000	-6%	-$32K	0.05%	162
2014 Q3	$560K	Sell	167,300 -52,000	-24%	-$162K	0.06%	161
2014 Q2	$912K	Buy	219,300 +91,000	+71%	+$482K	0.09%	126
2014 Q1	$1.02M	Hold	128,300	–	–	0.11%	115
2013 Q4	$905K	Buy	128,300 +5,000	+4%	+$33.3K	0.1%	121
2013 Q3	$911K	Hold	123,300	–	–	0.1%	113
2013 Q2	$1.07M	Buy	+123,300	New	+$792K	0.13%	98

Other funds holding NPTN

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Shufro Rose & Co's NPTN Position: Q2 2015 in Review

Shufro Rose & Co sold out of NEOPHOTONICS CORP (NPTN) in Q2 2015, closing a stake of 112,300 shares — an estimated $758K sold.

Shufro Rose & Co first reported a position in NPTN in Q2 2013 and held it in 8 quarters. The position peaked at $1.07M in Q2 2013. 104 funds tracked by Wall St. Rank hold NPTN as of Q2 2015.

Shufro Rose & Co reported no remaining NEOPHOTONICS CORP position as of Q2 2015 after selling out during the quarter.
Shufro Rose & Co sold 112,300 NEOPHOTONICS CORP shares in Q2 2015, an estimated $758K.
Shufro Rose & Co first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 8 quarters.
Shufro Rose & Co's NEOPHOTONICS CORP position peaked at $1.07M in Q2 2013.
104 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2015.

Based on Shufro Rose & Co's 13F filing for Q2 2015, filed 30 Jul 2015.